{
    "hands_on_practices": [
        {
            "introduction": "The Michaelis-Menten model is a cornerstone for understanding enzyme function, describing how reaction velocity responds to substrate concentration. A missense variant can impair an enzyme by altering its catalytic turnover rate ($k_{\\mathrm{cat}}$) or its affinity for its substrate (inversely related to $K_M$). This exercise allows you to directly calculate and compare the performance of a wild-type versus a variant enzyme, illustrating how a single amino acid change translates into a quantifiable biochemical deficit ().",
            "id": "5032692",
            "problem": "A missense coding variant in a human metabolic enzyme alters its kinetic properties relative to the wild type. According to the Central Dogma of Molecular Biology (DNA $\\rightarrow$ RNA $\\rightarrow$ protein), a change in the protein sequence can modify enzyme function by changing the turnover number and substrate affinity. The variant is observed to have a reduced turnover number and decreased apparent substrate affinity compared to the wild type, characterized by the following parameters: wild-type turnover number $k_{\\mathrm{cat}}=100\\ \\text{s}^{-1}$, wild-type Michaelis constant $K_{M}=20\\ \\mu\\text{M}$; variant turnover number $k_{\\mathrm{cat}}=10\\ \\text{s}^{-1}$, variant Michaelis constant $K_{M}=200\\ \\mu\\text{M}$. Assume an initial-rate regime where product accumulation is negligible and substrate concentration is much greater than enzyme concentration, with total enzyme concentration $[E]_{T}=50\\ \\text{nM}$. Using the steady-state framework for the single-substrate enzyme reaction $E+S\\rightleftharpoons ES\\rightarrow E+P$, compute the initial velocities for both wild-type and variant enzymes at substrate concentrations $[S]=5\\ \\mu\\text{M}$, $[S]=20\\ \\mu\\text{M}$, and $[S]=200\\ \\mu\\text{M}$. Express all velocities in $\\mu\\text{M}\\,\\text{s}^{-1}$, round your results to four significant figures, and report the six values as a single row matrix in the order: wild-type at $[S]=5\\ \\mu\\text{M}$, wild-type at $[S]=20\\ \\mu\\text{M}$, wild-type at $[S]=200\\ \\mu\\text{M}$, variant at $[S]=5\\ \\mu\\text{M}$, variant at $[S]=20\\ \\mu\\text{M}$, variant at $[S]=200\\ \\mu\\text{M}$.",
            "solution": "The problem requires the calculation of initial reaction velocities for a wild-type enzyme and a missense variant using the Michaelis-Menten model. The reaction follows the scheme $E+S\\rightleftharpoons ES\\rightarrow E+P$.\n\nThe initial velocity $v_0$ of a single-substrate enzyme reaction following Michaelis-Menten kinetics is given by the equation:\n$$ v_0 = \\frac{V_{\\mathrm{max}}[S]}{K_M + [S]} $$\nwhere $V_{\\mathrm{max}}$ is the maximum velocity, $K_M$ is the Michaelis constant, and $[S]$ is the substrate concentration. The maximum velocity $V_{\\mathrm{max}}$ is related to the turnover number $k_{\\mathrm{cat}}$ and the total enzyme concentration $[E]_T$ by the expression:\n$$ V_{\\mathrm{max}} = k_{\\mathrm{cat}} [E]_T $$\nSubstituting this into the Michaelis-Menten equation yields the form we will use for calculation:\n$$ v_0 = \\frac{k_{\\mathrm{cat}} [E]_T [S]}{K_M + [S]} $$\nThe problem provides data with mixed units. The substrate concentration $[S]$ and Michaelis constant $K_M$ are in $\\mu\\mathrm{M}$, while the total enzyme concentration $[E]_T$ is in $\\mathrm{nM}$. To ensure dimensional consistency and to obtain the final velocity in the requested units of $\\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$, we must express all concentration terms in $\\mu\\mathrm{M}$. The turnover number $k_{\\mathrm{cat}}$ is given in $\\mathrm{s}^{-1}$.\nThe total enzyme concentration is given as $[E]_T = 50\\ \\mathrm{nM}$. We convert this to $\\mu\\mathrm{M}$:\n$$ [E]_T = 50\\ \\mathrm{nM} = 50 \\times 10^{-3}\\ \\mu\\mathrm{M} = 0.050\\ \\mu\\mathrm{M} $$\n\nWe will now calculate the initial velocities for both the wild-type and variant enzymes at the three specified substrate concentrations.\n\n**1. Wild-Type (WT) Enzyme Calculations**\nThe parameters for the wild-type enzyme are $k_{\\mathrm{cat, WT}} = 100\\ \\mathrm{s}^{-1}$ and $K_{M, \\mathrm{WT}} = 20\\ \\mu\\mathrm{M}$.\nFirst, we determine the maximum velocity for the wild-type enzyme:\n$$ V_{\\mathrm{max, WT}} = k_{\\mathrm{cat, WT}} [E]_T = (100\\ \\mathrm{s}^{-1})(0.050\\ \\mu\\mathrm{M}) = 5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nNow we compute the velocities at the specified substrate concentrations:\n\na) For $[S] = 5\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{WT}} = \\frac{(5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(5\\ \\mu\\mathrm{M})}{20\\ \\mu\\mathrm{M} + 5\\ \\mu\\mathrm{M}} = \\frac{25}{25}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = 1.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $1.000\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nb) For $[S] = 20\\ \\mu\\mathrm{M}$ (which is equal to $K_{M, \\mathrm{WT}}$):\n$$ v_{0, \\mathrm{WT}} = \\frac{(5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(20\\ \\mu\\mathrm{M})}{20\\ \\mu\\mathrm{M} + 20\\ \\mu\\mathrm{M}} = \\frac{100}{40}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = 2.5\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nAs expected, the velocity is exactly half of $V_{\\mathrm{max, WT}}$. Rounded to four significant figures, the velocity is $2.500\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nc) For $[S] = 200\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{WT}} = \\frac{(5.0\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(200\\ \\mu\\mathrm{M})}{20\\ \\mu\\mathrm{M} + 200\\ \\mu\\mathrm{M}} = \\frac{1000}{220}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = \\frac{50}{11}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} \\approx 4.54545\\dots\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $4.545\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\n**2. Variant (VAR) Enzyme Calculations**\nThe parameters for the variant enzyme are $k_{\\mathrm{cat, VAR}} = 10\\ \\mathrm{s}^{-1}$ and $K_{M, \\mathrm{VAR}} = 200\\ \\mu\\mathrm{M}$.\nFirst, we determine the maximum velocity for the variant enzyme:\n$$ V_{\\mathrm{max, VAR}} = k_{\\mathrm{cat, VAR}} [E]_T = (10\\ \\mathrm{s}^{-1})(0.050\\ \\mu\\mathrm{M}) = 0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nNow we compute the velocities at the specified substrate concentrations:\n\nd) For $[S] = 5\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{VAR}} = \\frac{(0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(5\\ \\mu\\mathrm{M})}{200\\ \\mu\\mathrm{M} + 5\\ \\mu\\mathrm{M}} = \\frac{2.5}{205}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = \\frac{1}{82}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} \\approx 0.012195\\dots\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $0.01220\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\ne) For $[S] = 20\\ \\mu\\mathrm{M}$:\n$$ v_{0, \\mathrm{VAR}} = \\frac{(0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(20\\ \\mu\\mathrm{M})}{200\\ \\mu\\mathrm{M} + 20\\ \\mu\\mathrm{M}} = \\frac{10}{220}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = \\frac{1}{22}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} \\approx 0.0454545\\dots\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nRounded to four significant figures, the velocity is $0.04545\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nf) For $[S] = 200\\ \\mu\\mathrm{M}$ (which is equal to $K_{M, \\mathrm{VAR}}$):\n$$ v_{0, \\mathrm{VAR}} = \\frac{(0.50\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1})(200\\ \\mu\\mathrm{M})}{200\\ \\mu\\mathrm{M} + 200\\ \\mu\\mathrm{M}} = \\frac{100}{400}\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} = 0.25\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1} $$\nAs expected, the velocity is exactly half of $V_{\\mathrm{max, VAR}}$. Rounded to four significant figures, the velocity is $0.2500\\ \\mu\\mathrm{M}\\,\\mathrm{s}^{-1}$.\n\nThe six computed velocities, rounded to four significant figures, are arranged in the specified order to form the final answer.",
            "answer": "$$\n\\boxed{\\begin{pmatrix} 1.000 & 2.500 & 4.545 & 0.01220 & 0.04545 & 0.2500 \\end{pmatrix}}\n$$"
        },
        {
            "introduction": "Many proteins must assemble into multi-subunit complexes to function, and in a heterozygote, a mutant subunit can sometimes interfere with the function of wild-type subunits in a phenomenon known as a dominant-negative effect. This practice uses fundamental probability to model the assembly of a tetrameric protein from a mix of wild-type and mutant subunits. It reveals how the presence of a faulty component can dramatically reduce the amount of functional protein complex, far more than a simple gene dosage model would predict ().",
            "id": "5032648",
            "problem": "A human gene encodes a receptor that functions only as a tetrameric complex of four identical subunits. Consider a heterozygous individual carrying one wild-type allele and one missense allele that produces a mutant subunit. Assume the following foundational facts and conditions hold:\n\n- By the Central Dogma of Molecular Biology, each allele is transcribed and translated into protein, and in a typical heterozygote with no allele-specific regulation, the two alleles contribute equally to the cellular pool of subunits.\n- The cellular pool of subunits contains a fraction $p$ of wild-type subunits and a fraction $1-p$ of mutant subunits. For a heterozygote with equal expression from each allele, take $p=\\frac{1}{2}$.\n- Tetramers assemble by random association from the pool, with each of the $4$ positions in a tetramer filled independently according to the pool fractions.\n- Any tetramer that contains at least one mutant subunit is functionally inactive; only tetramers composed entirely of wild-type subunits are functional.\n\nStarting from these principles and assumptions, derive the fraction of tetrameric complexes that are functional in this heterozygote. Express your final answer as an exact rational number (do not round; do not use a percentage sign).",
            "solution": "The problem statement is subjected to validation before a solution is attempted.\n\n**Step 1: Extract Givens**\n- The receptor is a tetrameric complex, meaning it is composed of $4$ identical subunits.\n- The individual is heterozygous, carrying one wild-type allele and one missense allele.\n- The two alleles contribute equally to the cellular pool of subunits.\n- The fraction of wild-type subunits in the pool is $p$.\n- The fraction of mutant subunits in the pool is $1-p$.\n- For the specified heterozygote, the value of $p$ is given as $p=\\frac{1}{2}$.\n- Tetramers assemble by random association from this pool.\n- Each of the $4$ positions in a tetramer is filled independently.\n- A tetramer is functional if and only if it is composed entirely of wild-type subunits. Any tetramer with one or more mutant subunits is non-functional.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem describes a classic dominant-negative effect, a well-established mechanism in genetics where a mutant protein interferes with the function of the wild-type protein. The assumptions of equal allelic expression and random subunit association are standard and appropriate for constructing a first-order model of this phenomenon.\n- **Well-Posed:** The problem provides a clear set of conditions and asks for a specific, calculable quantity. The parameters are defined, and a unique solution exists based on the principles of probability.\n- **Objective:** The language is formal, precise, and free of subjective or ambiguous terminology.\n\n**Step 3: Verdict and Action**\nThe problem is scientifically sound, well-posed, and objective. It is deemed **valid**. A solution will be derived.\n\nThe problem requires calculating the probability that a tetramer, assembled randomly from a pool of subunits, is functional. The key conditions are that the assembly of each subunit is an independent event and that functionality requires all four subunits to be of the wild-type form.\n\nLet $W$ denote the event that a randomly chosen subunit is wild-type, and let $M$ denote the event that it is mutant. From the problem statement, the probabilities of these events are:\n$$P(W) = p = \\frac{1}{2}$$\n$$P(M) = 1-p = 1 - \\frac{1}{2} = \\frac{1}{2}$$\n\nA tetramer is a complex of $4$ subunits. Let the four positions in the tetramer be denoted by $1$, $2$, $3$, and $4$. For the tetramer to be functional, the subunit at position $1$ must be wild-type, AND the subunit at position $2$ must be wild-type, AND the subunit at position $3$ must be wild-type, AND the subunit at position $4$ must be wild-type.\n\nSince the problem states that the subunits are chosen independently for each position, the probability of this compound event is the product of the probabilities of the individual events. Let $F$ be the event that a formed tetramer is functional.\n\n$$P(F) = P(\\text{position 1 is W} \\cap \\text{position 2 is W} \\cap \\text{position 3 is W} \\cap \\text{position 4 is W})$$\n\nBy independence, this becomes:\n$$P(F) = P(\\text{position 1 is W}) \\times P(\\text{position 2 is W}) \\times P(\\text{position 3 is W}) \\times P(\\text{position 4 is W})$$\n\nSubstituting the probability $P(W) = p$:\n$$P(F) = p \\times p \\times p \\times p = p^4$$\n\nNow, we substitute the specified value for $p$, which is $p = \\frac{1}{2}$ for a heterozygote with equal expression from both alleles.\n$$P(F) = \\left(\\frac{1}{2}\\right)^4$$\n\nCalculating this value gives the fraction of functional tetramers:\n$$P(F) = \\frac{1^4}{2^4} = \\frac{1}{16}$$\n\nThis scenario can also be described using the binomial probability formula, $P(k; n, p) = \\binom{n}{k} p^k (1-p)^{n-k}$, where $n$ is the number of trials (subunits in the complex), $k$ is the number of \"successes\" (wild-type subunits), and $p$ is the probability of a single success. Here, $n=4$ and we require $k=4$ for the complex to be functional.\n\n$$P(k=4) = \\binom{4}{4} \\left(\\frac{1}{2}\\right)^4 \\left(1-\\frac{1}{2}\\right)^{4-4}$$\n$$P(k=4) = (1) \\left(\\frac{1}{2}\\right)^4 \\left(\\frac{1}{2}\\right)^0$$\n$$P(k=4) = \\left(\\frac{1}{16}\\right) \\times 1 = \\frac{1}{16}$$\n\nBoth methods yield the same result. The fraction of tetrameric complexes that are functional is $\\frac{1}{16}$.",
            "answer": "$$\\boxed{\\frac{1}{16}}$$"
        },
        {
            "introduction": "Evaluating a novel variant for clinical significance requires synthesizing diverse lines of evidence, from computational predictions to functional assays and population data. This practice introduces the powerful Bayesian framework used to formalize the variant interpretation guidelines from the American College of Medical Genetics and Genomics (ACMG). By converting qualitative evidence categories into quantitative likelihood ratios, you will learn how to calculate a posterior probability of pathogenicity, providing a rigorous, evidence-based conclusion about a variant's role in disease ().",
            "id": "5032669",
            "problem": "A clinician evaluates a single-nucleotide coding variant in a gene where loss-of-function is an established disease mechanism. The evaluation follows the American College of Medical Genetics and Genomics (ACMG) categorical evidence framework. The categories applied to this variant are: one Pathogenic Very Strong ($\\text{PVS1}$) based on a predicted early truncating change consistent with loss-of-function, one Pathogenic Moderate ($\\text{PM}$) based on absence from large population datasets, two Pathogenic Supporting ($\\text{PP}$) based on multiple lines of in silico and conservation evidence suggesting a deleterious impact, and one Benign Strong ($\\text{BS}$) based on lack of segregation with disease in an adequately powered family.\n\nUse Bayes theorem as the fundamental base: posterior odds equal prior odds multiplied by the product of the likelihood ratios contributed by independent evidence. Assume the following widely used likelihood ratio mappings for ACMG categories: $\\text{PVS1} \\mapsto 350$, $\\text{PS} \\mapsto 18.7$, $\\text{PM} \\mapsto 4.3$, $\\text{PP} \\mapsto 2.08$, $\\text{BS} \\mapsto 0.0535$, and $\\text{BP} \\mapsto 0.4807$. Assume independence of these evidence lines. Let the prior probability of pathogenicity for a missense or truncating variant in this gene-disease context be $0.1$, reflecting pre-test knowledge of variant pathogenicity in this gene and disease.\n\nStarting from Bayes theorem and core definitions of odds and probability, derive an expression for the posterior odds of pathogenicity in terms of the prior odds and the evidence likelihood ratios, evaluate it for the specified evidence set, and convert the posterior odds to posterior probability. Express the final posterior probability of pathogenicity as a decimal and round your answer to four significant figures. Do not use a percentage sign.",
            "solution": "The problem requires the calculation of the posterior probability of pathogenicity for a genetic variant given a set of evidence criteria from the ACMG framework, a prior probability, and a set of likelihood ratio mappings for the evidence categories. The solution will proceed by first validating the problem statement and then performing the Bayesian calculation as requested.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n-   **Hypothesis:** The variant is pathogenic.\n-   **Established Disease Mechanism:** Loss-of-function.\n-   **Evidence Set:**\n    -   One Pathogenic Very Strong ($\\text{PVS1}$)\n    -   One Pathogenic Moderate ($\\text{PM}$)\n    -   Two Pathogenic Supporting ($\\text{PP}$)\n    -   One Benign Strong ($\\text{BS}$)\n-   **Likelihood Ratio (LR) Mappings:**\n    -   $LR(\\text{PVS1}) = 350$\n    -   $LR(\\text{PS}) = 18.7$\n    -   $LR(\\text{PM}) = 4.3$\n    -   $LR(\\text{PP}) = 2.08$\n    -   $LR(\\text{BS}) = 0.0535$\n    -   $LR(\\text{BP}) = 0.4807$\n-   **Assumption:** Independence of evidence lines.\n-   **Prior Probability of Pathogenicity:** $P(\\text{Pathogenic}) = 0.1$.\n-   **Fundamental Principle:** Bayes' theorem, expressed as: posterior odds = prior odds $\\times$ product of likelihood ratios.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed to be valid.\n-   **Scientifically Grounded:** The problem uses the standard ACMG/AMP framework for variant interpretation and a Bayesian approach to combine evidence, which is a recognized and published methodology in medical genetics (e.g., Tavtigian et al., 2018, Genetics in Medicine). The LR values provided are consistent with those proposed in the field.\n-   **Well-Posed:** All necessary information is providedâ€”prior probability, a complete set of evidence, and corresponding likelihood ratios. The task is clearly defined: derive an expression, evaluate it, and convert the result to a probability.\n-   **Objective:** The problem is stated using precise, quantitative language and standard terminology, free from subjectivity. The conflicting evidence (both pathogenic and benign criteria) represents a realistic clinical scenario, not a contradiction.\n-   **Completeness:** The problem is self-contained. The provided LRs for $\\text{PS}$ and $\\text{BP}$ are not needed for this specific evidence set, but their inclusion does not create ambiguity.\n\n**Step 3: Verdict and Action**\nThe problem is valid and a solution can be derived.\n\n### Derivation and Calculation\n\nLet $H_P$ be the hypothesis that the variant is pathogenic, and $H_B$ be the alternative hypothesis that it is benign. Let $E$ represent the collection of all observed evidence.\n\nThe prior probability of pathogenicity is given as $P(H_P) = 0.1$. The prior probability of being benign is therefore $P(H_B) = 1 - P(H_P) = 1 - 0.1 = 0.9$.\n\nFirst, we convert the prior probability to prior odds. The odds of an event are defined as the ratio of the probability of the event occurring to the probability of it not occurring.\n$$\n\\text{Odds}(H_P) = \\frac{P(H_P)}{P(H_B)} = \\frac{P(H_P)}{1 - P(H_P)}\n$$\nSubstituting the given prior probability:\n$$\n\\text{Odds}(H_P) = \\frac{0.1}{1 - 0.1} = \\frac{0.1}{0.9} = \\frac{1}{9}\n$$\nThe problem states that Bayes' theorem can be expressed in terms of odds and likelihood ratios (LR). The posterior odds of pathogenicity given the evidence $E$ are the product of the prior odds and the likelihood ratio for the evidence:\n$$\n\\text{Odds}(H_P | E) = \\text{Odds}(H_P) \\times LR(E)\n$$\nThe likelihood ratio for a piece of evidence $E_i$ is defined as $LR(E_i) = \\frac{P(E_i | H_P)}{P(E_i | H_B)}$. Given the assumption that the lines of evidence are independent, the total likelihood ratio for the set of evidence $E = \\{E_1, E_2, \\ldots, E_n\\}$ is the product of the individual likelihood ratios:\n$$\nLR(E) = \\prod_{i=1}^{n} LR(E_i)\n$$\nCombining these, the expression for the posterior odds is:\n$$\n\\text{Odds}(H_P | E) = \\left( \\frac{P(H_P)}{1 - P(H_P)} \\right) \\times \\prod_{i=1}^{n} LR(E_i)\n$$\nThis is the derived expression. Now we evaluate it for the specified evidence set. The evidence consists of one $\\text{PVS1}$, one $\\text{PM}$, two $\\text{PP}$, and one $\\text{BS}$ criterion. The combined likelihood ratio, $LR_{\\text{combined}}$, is:\n$$\nLR_{\\text{combined}} = LR(\\text{PVS1}) \\times LR(\\text{PM}) \\times LR(\\text{PP}) \\times LR(\\text{PP}) \\times LR(\\text{BS})\n$$\n$$\nLR_{\\text{combined}} = LR(\\text{PVS1}) \\times LR(\\text{PM}) \\times (LR(\\text{PP}))^{2} \\times LR(\\text{BS})\n$$\nSubstituting the given numerical values for the likelihood ratios:\n$$\nLR_{\\text{combined}} = 350 \\times 4.3 \\times (2.08)^{2} \\times 0.0535\n$$\n$$\nLR_{\\text{combined}} = 350 \\times 4.3 \\times 4.3264 \\times 0.0535\n$$\n$$\nLR_{\\text{combined}} = 1505 \\times 4.3264 \\times 0.0535 \\approx 348.3518\n$$\nNext, we calculate the posterior odds of pathogenicity:\n$$\n\\text{Odds}(H_P | E) = \\text{Odds}(H_P) \\times LR_{\\text{combined}} = \\frac{1}{9} \\times 348.3518 \\approx 38.70576\n$$\nFinally, we convert the posterior odds back to a posterior probability. The relationship between probability $P$ and odds is $P = \\frac{\\text{Odds}}{1 + \\text{Odds}}$. Therefore, the posterior probability of pathogenicity, $P(H_P | E)$, is:\n$$\nP(H_P | E) = \\frac{\\text{Odds}(H_P | E)}{1 + \\text{Odds}(H_P | E)}\n$$\n$$\nP(H_P | E) = \\frac{38.70576}{1 + 38.70576} = \\frac{38.70576}{39.70576} \\approx 0.9748166\n$$\nRounding the final answer to four significant figures as requested gives $0.9748$.",
            "answer": "$$ \\boxed{0.9748} $$"
        }
    ]
}